Events

Recall of ADVIA CENTAUR XP SYSTEM - C-PEPTIDE (CPS) ASSAY

According to Health Canada (via FOI), this recall involved a device in Canada that was produced by SIEMENS HEALTHCARE LIMITED.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    136055
  • Event Risk Class
    III
  • Event Initiated Date
    2014-03-28
  • Event Country
    Canada
  • Event Source
    HC
  • Notes / Alerts
    Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
  • Extra notes in the data
  • Reason
    Siemens healthcare diagnostics received customer feedback on the advia centaur systems c-peptide assay indicating a low but increased rate of signal 2 errors. a limited number of customers have experienced the signal 2 error codes. patient results cannot be generated if a signal 2 error is obtained. this issue has not been observed on the advia centaur cp.

Device

ADVIA CENTAUR XP SYSTEM - C-PEPTIDE (CPS) ASSAY
  • Model / Serial
    Model Catalog: 129026 (Lot serial: > 10 numbers contact mfg); Model Catalog: 03649928 (Lot serial: > 10 numbers contact mfg)
  • Product Description
    ADVIA CENTAUR XP SYSTEM - C-PEPTIDE (CPS) ASSAY
  • Manufacturer
    SIEMENS HEALTHCARE LIMITED

Manufacturer

SIEMENS HEALTHCARE LIMITED
  • Manufacturer Address
    OAKVILLE
  • Manufacturer Parent Company (2017)
    Siemens Ag
  • Source
    HC